Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blattella germanica allergens are a complex group of proteins produced by the German cockroach that serve as potent indoor aeroallergens. These proteins, including major allergens like Bla g 1, Bla g 2 (an aspartic protease), and Bla g 5 (a glutathione S-transferase), are found in cockroach secretions, feces, and decaying body parts (Pomés et al., 2017). Exposure to these allergens is a primary risk factor for the development of allergic sensitization and is strongly associated with the severity of asthma, particularly in urban populations (Arruda et al., 2001). The biological functions of these allergens vary, ranging from enzymatic activity to transport roles and structural muscle functions, which often leads to cross-reactivity with other invertebrates (WHO/IUIS, 2023). In a clinical context, these allergens are the targets of diagnostic tests and allergen-specific immunotherapy (AIT), which aims to induce immune tolerance. Modern therapeutic approaches also include monoclonal antibodies that target the underlying Th2 inflammatory pathway triggered by these allergens (NIH, 2022).
Allergen-specific immunotherapy (AIT) involves the repeated administration of allergen extracts to induce peripheral immune tolerance by increasing regulatory T cells (Tregs) and producing allergen-specific IgG4 antibodies, which compete with IgE for allergen binding and inhibit mast cell degranulation (Pomés et al., 2017).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blattella germanica allergens (Bla g).